Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

Item
http://www.wikidata.org/entity/Q33795052
Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast CancerCombined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM).Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer.Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorptionThe effect of ABCB1 genetic variants on chemotherapy response in HIV and cancer treatment.Impact of obesity on drug metabolism and elimination in adults and children.Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation.Effect of grapefruit juice on the pharmacokinetics of docetaxel in cancer patients: a case report.Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel.From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies.Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity.
P2860

Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.

Item
http://www.wikidata.org/entity/Q33795052
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Population pharmacokinetics of ...... patients with advanced cancer.
@ast
Population pharmacokinetics of ...... patients with advanced cancer.
@en
type
label
Population pharmacokinetics of ...... patients with advanced cancer.
@ast
Population pharmacokinetics of ...... patients with advanced cancer.
@en
prefLabel
Population pharmacokinetics of ...... patients with advanced cancer.
@ast
Population pharmacokinetics of ...... patients with advanced cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Population pharmacokinetics of ...... patients with advanced cancer.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-2125.2010.03621.X
P407
P433
P478
P577
P5875
P698
P932